- €138.70m
- €444.25m
- €766.75m
- 76
- 92
- 55
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 686 | 671 | 687 | 722 | 767 |
Cost of Revenue | |||||
Gross Profit | 565 | 558 | 565 | 590 | 629 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 664 | 671 | 676 | 703 | 754 |
Operating Profit | 22.4 | 0.151 | 11.6 | 19.5 | 12.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.6 | -10.1 | 2.45 | 9.78 | -8.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.68 | -9.03 | 1.49 | 9.72 | -10.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 9.66 | -9 | 1.46 | 9.44 | -10.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.66 | -9 | 1.46 | 9.44 | -10.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.203 | -0.209 | 0.031 | 0.199 | -0.145 |
Dividends per Share |